CV Therapeutics, Inc. (NASDAQ:CVTX.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on the discovery, development and commercialization of new small molecule drugs for the treatment of cardiovascular diseases.

CVTX.DL News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top CVTX.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

johnnymack91362 (26.07)
Submitted April 27, 2008

europe approvals and nice royalty situation, still are'nt being valued.

NetscribeBiotech (95.14)
Submitted January 08, 2007

CV Therapeutics is a development-stage company specializing in small-molecule drugs to treat chronic cardiovascular diseases. The firm's only marketed product Ranexa, licensed from a Roche subsidiary, treats chronic angina for select patients by… More

CVTX.DL VS S&P 500 (SPY)

CVTX.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about CVTX.DL.

No one has written a Pitch for CVTX.DL stock yet. Tell us why you think CVTX.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in CVTX.DL.

No players have picked CVTX.DL yet. Tell us why you think CVTX.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 84.80 3/13/2009 Underperform 3W $20.67 -3.19% +14.44% +17.64 4/18/2009 @ $20.01 0 Comment
trackbenchmark 99.59 2/23/2009 Outperform NS $15.70 +27.45% +11.26% +16.20 4/18/2009 @ $20.01 0 Comment
TrackJimCramer 84.80 6/15/2007 Outperform 3W $11.37 +81.79% -50.29% +132.08 3/14/2009 @ $20.67 0 Comment
TrackBroadpointAmTech < 20 4/25/2007 Outperform NS $8.71 +129.74% -41.45% +171.19 4/18/2009 @ $20.01 0 Comment
TrackCitigroup 93.16 3/28/2007 Underperform NS $7.47 +167.87% -38.74% -206.61 4/18/2009 @ $20.01 0 Comment
TrackDeutscheSec 90.05 3/26/2007 Underperform NS $7.67 +160.95% -39.32% -200.27 4/18/2009 @ $20.01 0 Comment
TrackCantorFitz 37.25 1/19/2007 Outperform NS $14.38 +39.15% -38.91% +78.06 4/18/2009 @ $20.01 0 Comment

Featured Broker Partners